Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...
Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback